CPT 84830: Luteinizing Hormone by Visual Color Comparison

Headline: CPT code 84830 defines a laboratory assay for luteinizing hormone measured by visual color comparison. Lead: CPT code 84830 identifies a laboratory procedure in which testing personnel determine human luteinizing hormone (LH) levels by matching color changes to a standardized chart. This visually read colorimetric method is used in clinical and hospital laboratory settings to provide rapid qualitative or semi-quantitative LH assessment.

CPT code 84830 matters nationally because LH testing is central to reproductive health evaluation, fertility workups, and endocrine assessments. The method specified by the code is distinct from instrument- or immunoassay-based quantitative testing and has implications for reporting, clinical interpretation, and laboratory workflows.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find national-context information on where this service fits clinically, typical sites of service, and the operational characterization of the procedure. The publication outlines benchmarking expectations, payer coverage patterns where available, and relevant clinical context for LH testing using visual color comparison. It also identifies gaps where data are not available in the input.

What readers will learn: an executive overview of CPT code 84830, the clinical uses of visually read LH tests, payer scope in the national context, and which topics require supplemental data for rate and utilization benchmarking.

Billing Code Overview

CPT code 84830 describes a laboratory test in which testing personnel measure human luteinizing hormone (LH) by visual color comparison to a standardized chart. The service type is laboratory diagnostic testing that uses a qualitative or semi-quantitative colorimetric visual assay. The typical site of service is a clinical laboratory or hospital laboratory where trained personnel perform and interpret the test visually.

Data not available in the input.

Clinical Context

A 28-year-old woman presents to an outpatient clinic concerned about irregular menstrual cycles and possible anovulation while attempting conception. The clinician performs a point-of-care urine luteinizing hormone (LH) test using a visual color-comparison kit to detect the LH surge that precedes ovulation. The testing personnel collect a urine specimen, perform the assay per manufacturer instructions, and interpret results by visually comparing the test line color intensity to a standardized chart. The result is documented in the medical record, and the clinician uses the result to time intercourse or further fertility evaluation. Typical sites of service include outpatient clinics, family planning centers, fertility clinics, and some urgent care settings where point-of-care urine ovulation testing is performed.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the professional interpretation component if the laboratory component is billed separately.
`TC`	Technical component	Use when billing only the technical component (test performance and materials) without professional interpretation.

Taxonomy Code	Specialty	Notes
207Q00000X	Reproductive Endocrinology & Infertility	Specialists who manage ovulatory disorders and fertility testing.
207L00000X	Obstetrics & Gynecology	Common site for point-of-care ovulation testing during fertility workup.
103K00000X	Family Medicine	Often performs point-of-care testing for cycle monitoring and counseling.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`N97.0`	Female infertility associated with anovulation	Direct indication for urine LH testing to detect ovulation timing and confirm anovulatory cycles.
`N91.2`	Oligomenorrhea (infrequent menstruation)	LH testing used to evaluate ovulatory function in patients with infrequent cycles.
`N92.6`	Irregular menstruation, unspecified	Ovulation prediction via LH testing assists in assessing causes of irregular menses.
`E28.2`	Polycystic ovarian syndrome (PCOS)	PCOS commonly causes anovulation; LH testing helps in cycle monitoring and fertility planning.
`R87.619`	Abnormal findings on cervical cytology, unspecified	Data not directly related to LH testing but may occur in gynecologic evaluation visits where point-of-care tests including LH are performed.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`81025`	Urinalysis, by dipstick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity; automated, without microscopy	Performed frequently in the same visit to assess urine quality and rule out infection or interfering substances prior to urine LH testing.
`82043`	Assay of estrone, estradiol, or estriol; other than fetus or newborn	Serum estradiol testing may be ordered alongside LH testing in fertility evaluation to assess follicular development.
`83001`	Qualitative urine pregnancy test, by visual color comparison methods (eg, diagnostic test strip)	Often performed concurrently to rule out pregnancy before ovulation-focused counseling; similar methodology to LH urine testing.
`84443`	Assay of follicle stimulating hormone (FSH)	Serum FSH is commonly obtained in fertility evaluation and may complement LH testing in assessing ovulatory status.
`99000`	Handling and/or conveyance of specimen	Used when specific specimen handling outside routine is billed (note: many payors do not separately reimburse).

OpenPayer

Summary & Overview